Global Influenza Therapeutics Market Research Report 2026(Status and Outlook)
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Influenza Therapeutics market size was estimated at USD 7497.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Therapeutics market.
Global Influenza Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.
Market Segmentation (by Type)
Vaccines
Drugs
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Influenza Therapeutics Market
Overview of the regional outlook of the Influenza Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Influenza Therapeutics market size was estimated at USD 7497.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Therapeutics market.
Global Influenza Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.
Market Segmentation (by Type)
Vaccines
Drugs
Market Segmentation (by Application)
Hospitals
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Influenza Therapeutics Market
Overview of the regional outlook of the Influenza Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Therapeutics
1.2 Key Market Segments
1.2.1 Influenza Therapeutics Segment by Type
1.2.2 Influenza Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Influenza Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Therapeutics Product Life Cycle
3.3 Global Influenza Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Influenza Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Therapeutics Market Competitive Situation and Trends
3.8.1 Influenza Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Influenza Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Influenza Therapeutics Market Size by Type (2020-2025)
6.4 Global Influenza Therapeutics Price by Type (2020-2025)
7 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Therapeutics Market Sales by Application (2020-2025)
7.3 Global Influenza Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Therapeutics Sales Growth Rate by Application (2020-2025)
8 INFLUENZA THERAPEUTICS MARKET SALES BY REGION
8.1 Global Influenza Therapeutics Sales by Region
8.1.1 Global Influenza Therapeutics Sales by Region
8.1.2 Global Influenza Therapeutics Sales Market Share by Region
8.2 Global Influenza Therapeutics Market Size by Region
8.2.1 Global Influenza Therapeutics Market Size by Region
8.2.2 Global Influenza Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Influenza Therapeutics Sales by Country
8.3.2 North America Influenza Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Therapeutics Sales by Country
8.4.2 Europe Influenza Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Therapeutics Sales by Region
8.5.2 Asia Pacific Influenza Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Therapeutics Sales by Country
8.6.2 South America Influenza Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Therapeutics Sales by Region
8.7.2 Middle East and Africa Influenza Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Therapeutics by Region(2020-2025)
9.2 Global Influenza Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Therapeutics Production
9.4.1 North America Influenza Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Therapeutics Production
9.5.1 Europe Influenza Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Therapeutics Production (2020-2025)
9.6.1 Japan Influenza Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Therapeutics Production (2020-2025)
9.7.1 China Influenza Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Influenza Therapeutics Product Overview
10.1.3 Abbott Laboratories Influenza Therapeutics Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Astrazeneca PLC
10.2.1 Astrazeneca PLC Basic Information
10.2.2 Astrazeneca PLC Influenza Therapeutics Product Overview
10.2.3 Astrazeneca PLC Influenza Therapeutics Product Market Performance
10.2.4 Astrazeneca PLC Business Overview
10.2.5 Astrazeneca PLC SWOT Analysis
10.2.6 Astrazeneca PLC Recent Developments
10.3 Biocryst Pharmaceuticals, Inc.
10.3.1 Biocryst Pharmaceuticals, Inc. Basic Information
10.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
10.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Market Performance
10.3.4 Biocryst Pharmaceuticals, Inc. Business Overview
10.3.5 Biocryst Pharmaceuticals, Inc. SWOT Analysis
10.3.6 Biocryst Pharmaceuticals, Inc. Recent Developments
10.4 Chiron Corporation
10.4.1 Chiron Corporation Basic Information
10.4.2 Chiron Corporation Influenza Therapeutics Product Overview
10.4.3 Chiron Corporation Influenza Therapeutics Product Market Performance
10.4.4 Chiron Corporation Business Overview
10.4.5 Chiron Corporation Recent Developments
10.5 CSL Limited
10.5.1 CSL Limited Basic Information
10.5.2 CSL Limited Influenza Therapeutics Product Overview
10.5.3 CSL Limited Influenza Therapeutics Product Market Performance
10.5.4 CSL Limited Business Overview
10.5.5 CSL Limited Recent Developments
10.6 Daiichi Sankyo Co., Ltd.
10.6.1 Daiichi Sankyo Co., Ltd. Basic Information
10.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
10.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Market Performance
10.6.4 Daiichi Sankyo Co., Ltd. Business Overview
10.6.5 Daiichi Sankyo Co., Ltd. Recent Developments
10.7 Glaxosmithkline PLC
10.7.1 Glaxosmithkline PLC Basic Information
10.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Overview
10.7.3 Glaxosmithkline PLC Influenza Therapeutics Product Market Performance
10.7.4 Glaxosmithkline PLC Business Overview
10.7.5 Glaxosmithkline PLC Recent Developments
10.8 Mitsubishi Tanabe Pharma Corporation
10.8.1 Mitsubishi Tanabe Pharma Corporation Basic Information
10.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
10.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Market Performance
10.8.4 Mitsubishi Tanabe Pharma Corporation Business Overview
10.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
10.9 Nanotherapeutics Inc.
10.9.1 Nanotherapeutics Inc. Basic Information
10.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Overview
10.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product Market Performance
10.9.4 Nanotherapeutics Inc. Business Overview
10.9.5 Nanotherapeutics Inc. Recent Developments
10.10 Protein Sciences Corporation
10.10.1 Protein Sciences Corporation Basic Information
10.10.2 Protein Sciences Corporation Influenza Therapeutics Product Overview
10.10.3 Protein Sciences Corporation Influenza Therapeutics Product Market Performance
10.10.4 Protein Sciences Corporation Business Overview
10.10.5 Protein Sciences Corporation Recent Developments
10.11 Roche Holding AG
10.11.1 Roche Holding AG Basic Information
10.11.2 Roche Holding AG Influenza Therapeutics Product Overview
10.11.3 Roche Holding AG Influenza Therapeutics Product Market Performance
10.11.4 Roche Holding AG Business Overview
10.11.5 Roche Holding AG Recent Developments
10.12 Sanofi SA
10.12.1 Sanofi SA Basic Information
10.12.2 Sanofi SA Influenza Therapeutics Product Overview
10.12.3 Sanofi SA Influenza Therapeutics Product Market Performance
10.12.4 Sanofi SA Business Overview
10.12.5 Sanofi SA Recent Developments
10.13 Shionogi and Co., Ltd.
10.13.1 Shionogi and Co., Ltd. Basic Information
10.13.2 Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
10.13.3 Shionogi and Co., Ltd. Influenza Therapeutics Product Market Performance
10.13.4 Shionogi and Co., Ltd. Business Overview
10.13.5 Shionogi and Co., Ltd. Recent Developments
10.14 Sinovac Biotech Ltd.
10.14.1 Sinovac Biotech Ltd. Basic Information
10.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
10.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product Market Performance
10.14.4 Sinovac Biotech Ltd. Business Overview
10.14.5 Sinovac Biotech Ltd. Recent Developments
11 INFLUENZA THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Influenza Therapeutics Market Size Forecast
11.2 Global Influenza Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Therapeutics Market Size Forecast by Region
11.2.4 South America Influenza Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Influenza Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Influenza Therapeutics by Type (2026-2035)
12.1.2 Global Influenza Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Influenza Therapeutics by Type (2026-2035)
12.2 Global Influenza Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Influenza Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Influenza Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Therapeutics
1.2 Key Market Segments
1.2.1 Influenza Therapeutics Segment by Type
1.2.2 Influenza Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Influenza Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Therapeutics Product Life Cycle
3.3 Global Influenza Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Influenza Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Therapeutics Market Competitive Situation and Trends
3.8.1 Influenza Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Influenza Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Influenza Therapeutics Market Size by Type (2020-2025)
6.4 Global Influenza Therapeutics Price by Type (2020-2025)
7 INFLUENZA THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Therapeutics Market Sales by Application (2020-2025)
7.3 Global Influenza Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Therapeutics Sales Growth Rate by Application (2020-2025)
8 INFLUENZA THERAPEUTICS MARKET SALES BY REGION
8.1 Global Influenza Therapeutics Sales by Region
8.1.1 Global Influenza Therapeutics Sales by Region
8.1.2 Global Influenza Therapeutics Sales Market Share by Region
8.2 Global Influenza Therapeutics Market Size by Region
8.2.1 Global Influenza Therapeutics Market Size by Region
8.2.2 Global Influenza Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Influenza Therapeutics Sales by Country
8.3.2 North America Influenza Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Therapeutics Sales by Country
8.4.2 Europe Influenza Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Therapeutics Sales by Region
8.5.2 Asia Pacific Influenza Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Therapeutics Sales by Country
8.6.2 South America Influenza Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Therapeutics Sales by Region
8.7.2 Middle East and Africa Influenza Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Therapeutics by Region(2020-2025)
9.2 Global Influenza Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Therapeutics Production
9.4.1 North America Influenza Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Therapeutics Production
9.5.1 Europe Influenza Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Therapeutics Production (2020-2025)
9.6.1 Japan Influenza Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Therapeutics Production (2020-2025)
9.7.1 China Influenza Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Influenza Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Influenza Therapeutics Product Overview
10.1.3 Abbott Laboratories Influenza Therapeutics Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Astrazeneca PLC
10.2.1 Astrazeneca PLC Basic Information
10.2.2 Astrazeneca PLC Influenza Therapeutics Product Overview
10.2.3 Astrazeneca PLC Influenza Therapeutics Product Market Performance
10.2.4 Astrazeneca PLC Business Overview
10.2.5 Astrazeneca PLC SWOT Analysis
10.2.6 Astrazeneca PLC Recent Developments
10.3 Biocryst Pharmaceuticals, Inc.
10.3.1 Biocryst Pharmaceuticals, Inc. Basic Information
10.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
10.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Market Performance
10.3.4 Biocryst Pharmaceuticals, Inc. Business Overview
10.3.5 Biocryst Pharmaceuticals, Inc. SWOT Analysis
10.3.6 Biocryst Pharmaceuticals, Inc. Recent Developments
10.4 Chiron Corporation
10.4.1 Chiron Corporation Basic Information
10.4.2 Chiron Corporation Influenza Therapeutics Product Overview
10.4.3 Chiron Corporation Influenza Therapeutics Product Market Performance
10.4.4 Chiron Corporation Business Overview
10.4.5 Chiron Corporation Recent Developments
10.5 CSL Limited
10.5.1 CSL Limited Basic Information
10.5.2 CSL Limited Influenza Therapeutics Product Overview
10.5.3 CSL Limited Influenza Therapeutics Product Market Performance
10.5.4 CSL Limited Business Overview
10.5.5 CSL Limited Recent Developments
10.6 Daiichi Sankyo Co., Ltd.
10.6.1 Daiichi Sankyo Co., Ltd. Basic Information
10.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
10.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Market Performance
10.6.4 Daiichi Sankyo Co., Ltd. Business Overview
10.6.5 Daiichi Sankyo Co., Ltd. Recent Developments
10.7 Glaxosmithkline PLC
10.7.1 Glaxosmithkline PLC Basic Information
10.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Overview
10.7.3 Glaxosmithkline PLC Influenza Therapeutics Product Market Performance
10.7.4 Glaxosmithkline PLC Business Overview
10.7.5 Glaxosmithkline PLC Recent Developments
10.8 Mitsubishi Tanabe Pharma Corporation
10.8.1 Mitsubishi Tanabe Pharma Corporation Basic Information
10.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
10.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Market Performance
10.8.4 Mitsubishi Tanabe Pharma Corporation Business Overview
10.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
10.9 Nanotherapeutics Inc.
10.9.1 Nanotherapeutics Inc. Basic Information
10.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Overview
10.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product Market Performance
10.9.4 Nanotherapeutics Inc. Business Overview
10.9.5 Nanotherapeutics Inc. Recent Developments
10.10 Protein Sciences Corporation
10.10.1 Protein Sciences Corporation Basic Information
10.10.2 Protein Sciences Corporation Influenza Therapeutics Product Overview
10.10.3 Protein Sciences Corporation Influenza Therapeutics Product Market Performance
10.10.4 Protein Sciences Corporation Business Overview
10.10.5 Protein Sciences Corporation Recent Developments
10.11 Roche Holding AG
10.11.1 Roche Holding AG Basic Information
10.11.2 Roche Holding AG Influenza Therapeutics Product Overview
10.11.3 Roche Holding AG Influenza Therapeutics Product Market Performance
10.11.4 Roche Holding AG Business Overview
10.11.5 Roche Holding AG Recent Developments
10.12 Sanofi SA
10.12.1 Sanofi SA Basic Information
10.12.2 Sanofi SA Influenza Therapeutics Product Overview
10.12.3 Sanofi SA Influenza Therapeutics Product Market Performance
10.12.4 Sanofi SA Business Overview
10.12.5 Sanofi SA Recent Developments
10.13 Shionogi and Co., Ltd.
10.13.1 Shionogi and Co., Ltd. Basic Information
10.13.2 Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
10.13.3 Shionogi and Co., Ltd. Influenza Therapeutics Product Market Performance
10.13.4 Shionogi and Co., Ltd. Business Overview
10.13.5 Shionogi and Co., Ltd. Recent Developments
10.14 Sinovac Biotech Ltd.
10.14.1 Sinovac Biotech Ltd. Basic Information
10.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
10.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product Market Performance
10.14.4 Sinovac Biotech Ltd. Business Overview
10.14.5 Sinovac Biotech Ltd. Recent Developments
11 INFLUENZA THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Influenza Therapeutics Market Size Forecast
11.2 Global Influenza Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Therapeutics Market Size Forecast by Region
11.2.4 South America Influenza Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Influenza Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Influenza Therapeutics by Type (2026-2035)
12.1.2 Global Influenza Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Influenza Therapeutics by Type (2026-2035)
12.2 Global Influenza Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Influenza Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Influenza Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Therapeutics Market Size by Type (M USD)
Table 4. Global Influenza Therapeutics Market Size by Application
Table 5. Influenza Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Influenza Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Influenza Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2025)
Table 11. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Influenza Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza Therapeutics Sales by Type (K Units)
Table 27. Global Influenza Therapeutics Market Size by Type (M USD)
Table 28. Global Influenza Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Influenza Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Influenza Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza Therapeutics Market Share by Type (2020-2025)
Table 32. Global Influenza Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Influenza Therapeutics Sales (K Units) by Application
Table 34. Global Influenza Therapeutics Market Size by Application
Table 35. Global Influenza Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Influenza Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Influenza Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza Therapeutics Market Share by Application (2020-2025)
Table 39. Global Influenza Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Influenza Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Influenza Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza Therapeutics Market Size by Region (2020-2025)
Table 44. North America Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Influenza Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Influenza Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Influenza Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Influenza Therapeutics Product Overview
Table 64. Abbott Laboratories Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Astrazeneca PLC Basic Information
Table 69. Astrazeneca PLC Influenza Therapeutics Product Overview
Table 70. Astrazeneca PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Astrazeneca PLC Business Overview
Table 72. Astrazeneca PLC SWOT Analysis
Table 73. Astrazeneca PLC Recent Developments
Table 74. Biocryst Pharmaceuticals, Inc. Basic Information
Table 75. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
Table 76. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Biocryst Pharmaceuticals, Inc. Business Overview
Table 78. Biocryst Pharmaceuticals, Inc. SWOT Analysis
Table 79. Biocryst Pharmaceuticals, Inc. Recent Developments
Table 80. Chiron Corporation Basic Information
Table 81. Chiron Corporation Influenza Therapeutics Product Overview
Table 82. Chiron Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chiron Corporation Business Overview
Table 84. Chiron Corporation Recent Developments
Table 85. CSL Limited Basic Information
Table 86. CSL Limited Influenza Therapeutics Product Overview
Table 87. CSL Limited Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. CSL Limited Business Overview
Table 89. CSL Limited Recent Developments
Table 90. Daiichi Sankyo Co., Ltd. Basic Information
Table 91. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
Table 92. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Daiichi Sankyo Co., Ltd. Business Overview
Table 94. Daiichi Sankyo Co., Ltd. Recent Developments
Table 95. Glaxosmithkline PLC Basic Information
Table 96. Glaxosmithkline PLC Influenza Therapeutics Product Overview
Table 97. Glaxosmithkline PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Glaxosmithkline PLC Business Overview
Table 99. Glaxosmithkline PLC Recent Developments
Table 100. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 101. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
Table 102. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 104. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 105. Nanotherapeutics Inc. Basic Information
Table 106. Nanotherapeutics Inc. Influenza Therapeutics Product Overview
Table 107. Nanotherapeutics Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Nanotherapeutics Inc. Business Overview
Table 109. Nanotherapeutics Inc. Recent Developments
Table 110. Protein Sciences Corporation Basic Information
Table 111. Protein Sciences Corporation Influenza Therapeutics Product Overview
Table 112. Protein Sciences Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Protein Sciences Corporation Business Overview
Table 114. Protein Sciences Corporation Recent Developments
Table 115. Roche Holding AG Basic Information
Table 116. Roche Holding AG Influenza Therapeutics Product Overview
Table 117. Roche Holding AG Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Roche Holding AG Business Overview
Table 119. Roche Holding AG Recent Developments
Table 120. Sanofi SA Basic Information
Table 121. Sanofi SA Influenza Therapeutics Product Overview
Table 122. Sanofi SA Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi SA Business Overview
Table 124. Sanofi SA Recent Developments
Table 125. Shionogi and Co., Ltd. Basic Information
Table 126. Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
Table 127. Shionogi and Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Shionogi and Co., Ltd. Business Overview
Table 129. Shionogi and Co., Ltd. Recent Developments
Table 130. Sinovac Biotech Ltd. Basic Information
Table 131. Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
Table 132. Sinovac Biotech Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sinovac Biotech Ltd. Business Overview
Table 134. Sinovac Biotech Ltd. Recent Developments
Table 135. Global Influenza Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Influenza Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Influenza Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Influenza Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Influenza Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Influenza Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Influenza Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Influenza Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Influenza Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Influenza Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Influenza Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Influenza Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Influenza Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Therapeutics Market Size by Type (M USD)
Table 4. Global Influenza Therapeutics Market Size by Application
Table 5. Influenza Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Influenza Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Influenza Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Therapeutics as of 2025)
Table 11. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Influenza Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza Therapeutics Sales by Type (K Units)
Table 27. Global Influenza Therapeutics Market Size by Type (M USD)
Table 28. Global Influenza Therapeutics Sales (K Units) by Type (2020-2025)
Table 29. Global Influenza Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Influenza Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza Therapeutics Market Share by Type (2020-2025)
Table 32. Global Influenza Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Influenza Therapeutics Sales (K Units) by Application
Table 34. Global Influenza Therapeutics Market Size by Application
Table 35. Global Influenza Therapeutics Sales by Application (2020-2025) & (K Units)
Table 36. Global Influenza Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Influenza Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza Therapeutics Market Share by Application (2020-2025)
Table 39. Global Influenza Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza Therapeutics Sales by Region (2020-2025) & (K Units)
Table 41. Global Influenza Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Influenza Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza Therapeutics Market Size by Region (2020-2025)
Table 44. North America Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 45. North America Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza Therapeutics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Influenza Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza Therapeutics Sales by Country (2020-2025) & (K Units)
Table 51. South America Influenza Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza Therapeutics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Influenza Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza Therapeutics Production (K Units) by Region(2020-2025)
Table 55. Global Influenza Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Influenza Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Influenza Therapeutics Product Overview
Table 64. Abbott Laboratories Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Astrazeneca PLC Basic Information
Table 69. Astrazeneca PLC Influenza Therapeutics Product Overview
Table 70. Astrazeneca PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Astrazeneca PLC Business Overview
Table 72. Astrazeneca PLC SWOT Analysis
Table 73. Astrazeneca PLC Recent Developments
Table 74. Biocryst Pharmaceuticals, Inc. Basic Information
Table 75. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Overview
Table 76. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Biocryst Pharmaceuticals, Inc. Business Overview
Table 78. Biocryst Pharmaceuticals, Inc. SWOT Analysis
Table 79. Biocryst Pharmaceuticals, Inc. Recent Developments
Table 80. Chiron Corporation Basic Information
Table 81. Chiron Corporation Influenza Therapeutics Product Overview
Table 82. Chiron Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chiron Corporation Business Overview
Table 84. Chiron Corporation Recent Developments
Table 85. CSL Limited Basic Information
Table 86. CSL Limited Influenza Therapeutics Product Overview
Table 87. CSL Limited Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. CSL Limited Business Overview
Table 89. CSL Limited Recent Developments
Table 90. Daiichi Sankyo Co., Ltd. Basic Information
Table 91. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Overview
Table 92. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Daiichi Sankyo Co., Ltd. Business Overview
Table 94. Daiichi Sankyo Co., Ltd. Recent Developments
Table 95. Glaxosmithkline PLC Basic Information
Table 96. Glaxosmithkline PLC Influenza Therapeutics Product Overview
Table 97. Glaxosmithkline PLC Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Glaxosmithkline PLC Business Overview
Table 99. Glaxosmithkline PLC Recent Developments
Table 100. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 101. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Overview
Table 102. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 104. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 105. Nanotherapeutics Inc. Basic Information
Table 106. Nanotherapeutics Inc. Influenza Therapeutics Product Overview
Table 107. Nanotherapeutics Inc. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Nanotherapeutics Inc. Business Overview
Table 109. Nanotherapeutics Inc. Recent Developments
Table 110. Protein Sciences Corporation Basic Information
Table 111. Protein Sciences Corporation Influenza Therapeutics Product Overview
Table 112. Protein Sciences Corporation Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Protein Sciences Corporation Business Overview
Table 114. Protein Sciences Corporation Recent Developments
Table 115. Roche Holding AG Basic Information
Table 116. Roche Holding AG Influenza Therapeutics Product Overview
Table 117. Roche Holding AG Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Roche Holding AG Business Overview
Table 119. Roche Holding AG Recent Developments
Table 120. Sanofi SA Basic Information
Table 121. Sanofi SA Influenza Therapeutics Product Overview
Table 122. Sanofi SA Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi SA Business Overview
Table 124. Sanofi SA Recent Developments
Table 125. Shionogi and Co., Ltd. Basic Information
Table 126. Shionogi and Co., Ltd. Influenza Therapeutics Product Overview
Table 127. Shionogi and Co., Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Shionogi and Co., Ltd. Business Overview
Table 129. Shionogi and Co., Ltd. Recent Developments
Table 130. Sinovac Biotech Ltd. Basic Information
Table 131. Sinovac Biotech Ltd. Influenza Therapeutics Product Overview
Table 132. Sinovac Biotech Ltd. Influenza Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sinovac Biotech Ltd. Business Overview
Table 134. Sinovac Biotech Ltd. Recent Developments
Table 135. Global Influenza Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Influenza Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Influenza Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Influenza Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Influenza Therapeutics Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Influenza Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Influenza Therapeutics Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Influenza Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Influenza Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Influenza Therapeutics Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Influenza Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Influenza Therapeutics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Influenza Therapeutics Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Influenza Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Influenza Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Influenza Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Therapeutics Product Life Cycle
Figure 13. Influenza Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Influenza Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Influenza Therapeutics
Figure 19. Global Influenza Therapeutics Market PEST Analysis
Figure 20. Global Influenza Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Therapeutics Market Share by Type
Figure 27. Sales Market Share of Influenza Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Therapeutics by Type in 2025
Figure 29. Market Share of Influenza Therapeutics by Type (2020-2025)
Figure 30. Market Share of Influenza Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Therapeutics Market Share by Application
Figure 33. Global Influenza Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Influenza Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Influenza Therapeutics Market Share by Application in 2025
Figure 37. Global Influenza Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Influenza Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Therapeutics Market Size by Country in 2024
Figure 45. U.S. Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Influenza Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Therapeutics Market Size by Country in 2024
Figure 55. Germany Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Influenza Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Therapeutics Market Size by Region in 2024
Figure 68. China Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Influenza Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Influenza Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Therapeutics Market Size by Country in 2024
Figure 82. Brazil Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Influenza Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Influenza Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Influenza Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Influenza Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Influenza Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Influenza Therapeutics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Therapeutics Product Life Cycle
Figure 13. Influenza Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Influenza Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Influenza Therapeutics
Figure 19. Global Influenza Therapeutics Market PEST Analysis
Figure 20. Global Influenza Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Therapeutics Market Share by Type
Figure 27. Sales Market Share of Influenza Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Therapeutics by Type in 2025
Figure 29. Market Share of Influenza Therapeutics by Type (2020-2025)
Figure 30. Market Share of Influenza Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Therapeutics Market Share by Application
Figure 33. Global Influenza Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Influenza Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Influenza Therapeutics Market Share by Application in 2025
Figure 37. Global Influenza Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Influenza Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Therapeutics Market Size by Country in 2024
Figure 45. U.S. Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Influenza Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Therapeutics Market Size by Country in 2024
Figure 55. Germany Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Influenza Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Therapeutics Market Size by Region in 2024
Figure 68. China Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Influenza Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Influenza Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Therapeutics Market Size by Country in 2024
Figure 82. Brazil Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Influenza Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Influenza Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Influenza Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Influenza Therapeutics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Influenza Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza Therapeutics Market Share Forecast by Application (2026-2035)
